Big news ahead at #SABCS25! We will present eight new studies featuring real-world validation and utility of Ataraxis Breast RISK, head-to-head comparisons with genomic assays, and the first-ever data on Ataraxis Breast NEO, our new test for predicting response to neoadjuvant therapy. We look forward to connecting in San Antonio, December 9–12. Visit us at Booth 1408. Read more: https://lnkd.in/ehFanPvt
Fascinant de voir combien de nouvelles études seront présentées. Comment Ataraxis AI envisage-t-elle d'intégrer ces résultats dans des applications pratiques après le #SABCS25 ?
Go Ataraxis and Jan Witowski!
un modèle IA franchi donc une étape importante vers l'application en clinique, dans le cadre des protocoles de traitement du cancer du sein.
Exciting update! Huge milestone for Ataraxis can’t wait to see the new data at SABCS25.
Looking forward to seeing the abstracts after you present them!
Cindy Gallop - Please spread this around in your community
Award-Winning Automation & AI Leader | Global B2B Influencer & Recognized KOL | CEO@IAC.AI | $100M+ P&L Impact to Clients | Advisor | Speaker | Author
2dImpressive lineup at SABCS25 with Ataraxis breakthroughs reshaping breast cancer care. Can’t wait to see the impact unfold in San Antonio!